20 May 2013
Keywords: glead, viread, hiv, set, launch, usa, within
Article | 29 October 2001
The US Food and Drug Administration has awarded marketing approval toGilead Sciences for its antiretroviral agent Viread (tenofovir
disoproxil fumarate) ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
29 October 2001
30 October 2001
17 May 2013
© 2013 thepharmaletter.com